A two‐stage study was conducted in southern China to determine and validate an optimal
combination of Epstein‐Barr virus (EBV)‐related seromarkers for nasopharyngeal carcinoma (…

Background The value of adding cisplatin, fluorouracil, and docetaxel (TPF) induction
chemotherapy to concurrent chemoradiotherapy in locoregionally advanced nasopharyngeal …

Background Platinum-based concurrent chemoradiotherapy is the standard of care for patients
with locoregionally advanced nasopharyngeal carcinoma. Additional gemcitabine and …

Background Due to the occult anatomic location of the nasopharynx and frequent presence
of adenoid hyperplasia, the positive rate for malignancy identification during biopsy is low, …

PURPOSE: A prospective randomized trial was performed to evaluate the contribution of
neoadjuvant chemotherapy in patients with locoregionally advanced nasopharyngeal …

The Bmi-1 oncoprotein regulates proliferation and oncogenesis in human cells. Its
overexpression leads to senescence bypass in human fibroblasts and immortalization of human …

Background Concurrent chemoradiotherapy (CCRT) has been shown to improve outcomes
for stage III–IV nasopharyngeal carcinoma (NPC) patients compared with radiotherapy (RT) …

Background: This study aimed to establish an effective prognostic nomogram with or without
plasma Epstein-Barr virus DNA (EBV DNA) for nondisseminated nasopharyngeal …

Background The role of neoadjuvant chemotherapy (NACT) for locoregionally advanced
nasopharyngeal carcinoma (NPC) is unclear. We aimed to evaluate the feasibility and efficacy …

Nasopharyngeal carcinoma (NPC) occurs with high frequency in Asian populations,
especially among people of Cantonese ancestry. In areas with high incidence, NPC clusters in …